Formac Pharmaceuticals
Manufacturing · Belgium · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Gaston Geenslaan 1, Leuven, Flanders, 30...Phone Number
+32 16329780Website
www.formacpharma.comRevenue
<$5 MillionIndustry
About Formac Pharmaceuticals
Is Formac Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Formac Pharmaceuticals
Formac Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Formac Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Formac Pharmaceuticals has new funding data
Click to see if Formac Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Formac Pharmaceuticals recently announced quarterly report
Check out if Formac Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when Formac Pharmaceuticals launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Formac Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Formac Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Formac Pharmaceuticals.
Formac Pharmaceuticals Tech Stack
A closer look at the technologies used by Formac Pharmaceuticals
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Formac Pharmaceuticals
Formac is a spin-off company from the University of Leuven, Belgium (K.U.Leuven), from which it has obtained the exclusive and worldwide rights to develop and commercialise ordered mesoporous silica materials for the delivery of poorly soluble API's. The company was incorporated on 3 October 2007 and is privately owned. The main shareholders of For... Read More